celltrion healthcare

Temasek cuts stake in Celltrion and affiliate for $1b

Singapore’s sovereign wealth fund continues to fine-tune portfolio as it sells a small chunk of its shareholding in South Korea’s Celltrion and Celltrion Healthcare in overnight block deal.

March 07, 2018

Celltrion Healthcare IPO finally lifts off

The sales arm of drug maker Celltrion kicks off Korea's largest share sale this year hoping to match the success of other recent biopharma deals.

June 26, 2017

Korean biopharma looks for the perfect IPO formula

Expect a slew of biopharmaceutical IPOs from Korea, as companies capitalise on Seoul’s ambition to develop a biotechnology hub. That's if politics doesn't get in the way.

March 13, 2017